Influence of the HLA class II polymorphism in chronic Chagas' disease

被引:0
|
作者
Fernandez-Mestre, MT
Layrisse, Z
Montagnani, S
Acquatella, H
Catalioti, F
Matos, M
Balbas, O
Makhatadze, N
Dominguez, E
Herrera, F
Madrigal, A
机构
[1] Inst Venezolano Invest Cient, Ctr Med Expt, Caracas 1020A, Venezuela
[2] Ctr Invest Jose Francisco Torrealba, San Juan Morros, Venezuela
[3] Anthony Nolan Res Inst, London, England
关键词
MHC; HLA; DNA typing; Chagas' disease;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chagas' disease or American trypanosomiasis due to Trypanosoma cruzi has existed at least since the time of the Inca empire and contributes significantly to cardiovascular morbidity and mortality in several countries of this continent. Due to the fundamental role of human class II molecules polymorphic residues in the control of the immune response, a study was designed to define by DNA typing HLA class II alleles in a sample of 67 serologically positive individuals with and without cardiomyopathy and in 156 healthy controls of similar ethnic origin. Genomic DNA extraction, PCR amplification of the HLA-DRB1 and DQB1 second exon regions and hybridization to labelled specific probes were carried outfollowing the 11th International Histocompatibility Workshop reference protocol. Comparison of DRB1 and DQB1 allele frequencies among the patients and control subjects showed a decreased frequency of DRB1*14 and DeB1*0303 in the patients, suggesting independent protective effects to the chronic infection in this population. Allele frequencies comparison between patients with and without cardiomyopathy showed a higher frequency of DRB1*01, DRB1*08 and DQB1*0501 and a decreased frequency of DRB1*1501 in the patients with arrhitmia and congestive heart failure. The results suggest that HLA Class II genes may be associated with the development of a chronic infection and with heart damage in Chagas' disease.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 50 条
  • [21] HLA Class I and Class II Polymorphism in the Population of Vojvodina, Serbia
    Vojvodic, Svetlana
    Ademovic-Sazdanic, Dusica
    COLLEGIUM ANTROPOLOGICUM, 2012, 36 (04) : 1379 - 1384
  • [22] HLA class II associated polymorphism of interferon-gamma production - Implications for HLA-disease association
    Petrovsky, N
    Harrison, LC
    HUMAN IMMUNOLOGY, 1997, 53 (01) : 12 - 16
  • [23] The influence of the parasitemia on the evolution of the chronic Chagas' disease
    Castro, C
    Prata, A
    Macêdo, V
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2005, 38 (01) : 1 - 6
  • [24] A NEW APPROACH FOR THE ANALYSIS OF HLA CLASS-II POLYMORPHISM - HLA OLIGOTYPING
    TIERCY, JM
    JEANNET, M
    MACH, B
    BLOOD REVIEWS, 1990, 4 (01) : 9 - 15
  • [25] DNA POLYMORPHISM OF HLA CLASS-I AND CLASS-II REGIONS
    COHEN, D
    PAUL, P
    LEGALL, I
    MARCADET, A
    FONT, MP
    COHENHAGUENAUER, O
    SAYAGH, B
    CANN, H
    LALOUEL, JM
    DAUSSET, J
    IMMUNOLOGICAL REVIEWS, 1985, 85 : 87 - 105
  • [26] Study of the HLA class I and class II polymorphism in South Tunisian population
    Mahfoudh-Lahiani, Nadia
    Kamoun, Arwa
    Gaddour, Lilia
    Hakim, Faiza
    Makni, Hafedh
    TISSUE ANTIGENS, 2009, 73 (05): : 472 - 472
  • [27] Hla class I and class II polymorphism in a hybrid Venezuelan population.
    Makhatadze, NJ
    Franco, MT
    Dominguez, E
    Balducci, P
    Montagnani, S
    Herrera, F
    Layrisse, Z
    HUMAN IMMUNOLOGY, 1997, 55 : 117 - 117
  • [28] HLA class I and class II polymorphism in mitral chordae tendineae rupture
    Vatan, Mehmet Bulent
    Yigin, Aysel Kalayci
    Akdemir, Ramazan
    Agac, Mustafa Tarik
    Vatan, Asli
    Karacan, Keziban
    KUWAIT MEDICAL JOURNAL, 2023, 55 (02): : 133 - 138
  • [29] HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis
    Fernández-Mestre, MT
    Vargas, V
    Montagnani, S
    Cotúa, M
    Ogando, V
    Layrisse, Z
    HUMAN IMMUNOLOGY, 2004, 65 (01) : 54 - 59
  • [30] HLA class II polymorphism in Saudi patients with multiple sclerosis
    Al Jumah, M.
    Kojan, S.
    Al Shehri, A. M.
    Al Balwi, M.
    Al Abdulkarim, I.
    Masuadi, E. M.
    Alhaidan, Y.
    Alabdulrahman, A.
    Fakhoury, H. M.
    Hajeer, A. H.
    HLA, 2018, 91 (01) : 17 - 22